Black Friday saleUp to 70% OFF
III

INVEX THERAPEUTICS LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

IXC chart


Full chart

IXC upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.71 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.022 AUD
Net income (FY)
‪−1.64 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪74.85 M‬
Beta (1Y)
0.76

About INVEX THERAPEUTICS LTD


Sector
Health Technology
Industry
Biotechnology
Headquarters
Subiaco
Website
invextherapeutics.com
Founded
2019
ISIN
AU0000048621
FIGI
BBG00PD615S3
Invex Therapeutics Ltd. is a biopharmaceutical company, which engages in the research and development of treatment for neurological conditions resulting from raised intracranial pressure. It focuses on understanding and defining the mechanisms that regulate pressure in the brain and aims to repurpose and reformulate an already approved drug, Exenatide. The company was founded by Jason Loveridge and Alexandra J. Sinclair on March 8, 2019 and is headquartered in Subiaco, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

IXC news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IXC is 0.070 AUD — it has decreased by −7.89% in the past 24 hours. Watch INVEX THERAPEUTICS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange INVEX THERAPEUTICS LTD stocks are traded under the ticker IXC.
IXC stock has fallen by −12.50% compared to the previous week, the month change is a −9.09% fall, over the last year INVEX THERAPEUTICS LTD has showed a −69.57% decrease.
IXC reached its all-time high on May 22, 2020 with the price of 2.050 AUD, and its all-time low was 0.060 AUD and was reached on Dec 8, 2023. View more price dynamics on IXC chart.
See other stocks reaching their highest and lowest prices.
IXC stock is 8.57% volatile and has beta coefficient of 0.76. Track INVEX THERAPEUTICS LTD stock price on the chart and check out the list of the most volatile stocks — is INVEX THERAPEUTICS LTD there?
Today INVEX THERAPEUTICS LTD has the market capitalization of ‪5.71 M‬, it has decreased by −5.00% over the last week.
Yes, you can track INVEX THERAPEUTICS LTD financials in yearly and quarterly reports right on TradingView.
INVEX THERAPEUTICS LTD is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
IXC net income for the last half-year is ‪470.89 K‬ AUD, while the previous report showed ‪−2.11 M‬ AUD of net income which accounts for 122.29% change. Track more INVEX THERAPEUTICS LTD financial stats to get the full picture.
Like other stocks, IXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVEX THERAPEUTICS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INVEX THERAPEUTICS LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INVEX THERAPEUTICS LTD stock shows the sell signal. See more of INVEX THERAPEUTICS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.